PremiumThe FlyClearmind files international patent application for eating disorder treatment Psychedelic: Clearmind completes clinical site initiations for AUD trial Clearmind Medicine completes initiation of AUD Phase I/IIa trial PremiumThe FlyClearmind Medicine announces U.S. clinical site initiation for CMND-100 trial Clearmind announces patent application for psychedelic-based compounds Psychedelic: Enveric, Filament Health report earnings results PremiumThe FlyPsychedelic: atai Life Sciences, NRx report quarterly results Clearmind signs non-binding LOI with Polyrizon for intranasal drug delivery Clearmind Medicine initiates first in human clinical trial with CMND-100 
